Sidewinder Therapeutics vs Dataland
Side-by-side comparison of AI visibility scores, market position, and capabilities
Sidewinder Therapeutics raised $100M Series A in 2025 for its conditional activation platform that creates tumor-selective cancer drugs that only become active in the tumor microenvironment, reducing systemic toxicity.
About
Sidewinder Therapeutics is developing conditionally activated cancer therapeutics — drugs engineered to remain inert in circulation and become pharmacologically active only when they reach the tumor microenvironment. The approach exploits the unique biochemical conditions of solid tumors (acidic pH, hypoxia, tumor-specific proteases) to trigger drug activation, allowing far higher doses to be delivered to tumors with dramatically reduced side effects in healthy tissues.
NY no-code collaborative database with workflow automation received M&A offer April 2025; YC W20 $1M revenue competing with Airtable and Notion for business operations teams without SQL expertise.
About
Dataland is a New York-based no-code collaborative data management platform — backed by Y Combinator (W20) with funding from South Park Commons and Switch Ventures — providing business teams with a spreadsheet-like interface for centralizing, structuring, and automating business data workflows without SQL expertise, generating $1 million in revenue in 2024 with a 5-9 person team. Received an M&A offer in April 2025, positioning as a competitive alternative to Airtable and Notion in the growing no-code database market.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.